SCHEMBL8482178

SCHEMBL8482178

O=c1[nH]c2cc(Cl)cnc2[nH]c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 5/20 0.50
GRIN3B O60391 5/20 0.50
GRIN1 Q05586 5/20 0.50
GRIN2A Q12879 5/20 0.50
GRIN2B Q13224 5/20 0.50
GRIN2C Q14957 5/20 0.50
GRIN3A Q8TCU5 5/20 0.50
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
THPO P40225 1/20 0.46
GRIA1 P42261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8478807 0.78 DYRK1A (0.72) KDM4EALDH1A1KMT2AMEN1LMNA
SCHEMBL8478545 0.78 GRIN2D (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13384205 0.75 PRKD3 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13384510 0.73 MAP4K4 (0.40) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL13384203 0.73 PRKD3 (0.40) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8482774 0.73 JUN (0.43) KDM4EALDH1A1KMT2AMEN1LMNA
SCHEMBL19127152 0.72 DAO (0.44) KMT2AMEN1LMNADAOPABPC1
SCHEMBL8484491 0.72 NNMT (0.41) KMT2ASMN1; SMN2AURKADAPK3JAK2
SCHEMBL8478336 0.72 GRIA1 (0.54) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3359651 0.72 DAO (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5863916-A 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER-EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) 1999-01-26 US disclosed
US-5620978-A 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1997-04-15 US disclosed
EP-0743855-A1 8-AZA, 6-AZA AND 6,8-DIAZA-1,4-DIHYDROQUINOXALINE-2,3-DIONES AND THE USE THEREOF AS ANTAGONISTS FOR THE GLYCINE/NMDA RECEPTOR ACEA PHARMACEUTICALS, INC. (US) 1996-11-27 EP disclosed
WO-1995018616-A2 8-AZA, 6-AZA AND 6,8-DIAZA-1,4-DIHYDROQUINOXALINE-2,3-DIONES AND THE USE THEREOF AS ANTAGONISTS FOR THE GLYCINE/NMDA RECEPTOR ACEA PHARM INC (US) 1995-07-13 WO disclosed